(Inclusive of all taxes)
Abevmy 400 mg Injection is an anti-cancer medicine. Abevmy 400 mg Injection is used with other medicines to treat certain types of cancers, including Colon Cancer (A cancer of the colon or rectum), Non-Small Cell lung cancer (a group of lung cancers), Glioblastoma (Brain cancer), Kidney cancer, Ovarian cancer, etc. Abevmy 400 mg Injection is a monoclonal antibody that targets a protein called vascular endothelial growth factor (VEGF). VEGF plays a role in the growth of new blood vessels, and inhibiting its activity can help to slow the growth and spread of cancer cells.
Abevmy 400 mg Injection may result in some common adverse effects, such as dizziness, heartburn, loss of appetite, change in taste perception, diarrhoea, weight loss, skin or mouth sores, voice changes, and alterations in tear production. However, Abevmy 400 mg Injection may also lead to more severe side effects, such as an increased risk of bleeding and the development of new blood vessel growths in various organs and skin, as well as high blood pressure, kidney problems, and protein in the urine. In case of persistent or troublesome side effects, it is important to inform your physician immediately for further guidance.
Abevmy 400 mg Injection should be given intravenously. Your doctor will determine the appropriate dosage and frequency of administration based on the severity of your condition, which may be subject to change. It is important to follow your doctor's instructions for taking Abevmy 400 mg Injection, as improper or excessive intake may lead to severe adverse effects. Although it may take several weeks or months to observe the benefits of the medication, it is essential not to discontinue treatment unless your doctor tells you to.
Abevmy 400 mg Injection should not be used if you have a known allergy or hypersensitivity to Abevmy 400 mg Injection or any of its components. You should inform your doctor if you are using any prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products, Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may interact with Abevmy 400 mg Injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Inform your doctor if you are pregnant, planning pregnancy or breastfeeding. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.
Colorectal cancer: Abevmy 400 mg Injection is used to treat colorectal cancer is a type of cancer that affects the colon or rectum, which are part of the large intestine. The symptoms include changes in bowel habits (such as diarrhoea, constipation, or narrow stools). Blood in the stool. Abdominal pain or cramping. Weakness or fatigue, unintended weight loss.
Non-small cell lung cancer: Abevmy 400 mg Injection is used to treat non-small cell lung cancer, which is a type of lung cancer that affects a large number of cells in the lung. The symptoms may include persistent coughing, chest pain or discomfort, shortness of breath, hoarseness or other changes in voice, coughing up blood or rust-coloured sputum, and fatigue. Unintentional weight loss.
Glioblastoma(brain cancer): Abevmy 400 mg Injection is used in the treatment of glioblastoma a type of brain cancer that develops from glial cells, which are supportive cells that surround and protect neurons in the brain. The symptoms include headaches, seizures, nausea and vomiting, cognitive impairment or memory loss, personality changes or mood swings.
Kidney cancer: Abevmy 400 mg Injection is used in the treatment of kidney cancer that develops in the cells that line the small tubes within the kidney that filter waste from the blood. The symptoms include blood in the urine, pain or discomfort in the back or side, unintentional weight loss, fatigue, and swelling in the legs or ankles.
Ovarian cancer: Abevmy 400 mg Injection is used to treat ovarian cancer is a type of cancer that develops in the ovaries, the female reproductive organs that produce eggs. The symptoms include abdominal bloating or swelling, pain or discomfort in the pelvic region, feeling full quickly while eating, difficulty eating or feeling nauseous. Changes in bowel habits, such as constipation or diarrhoea, abnormal vaginal bleeding, and fatigue.
Abevmy 400 mg Injection can help to slow or stop the growth of cancer cells, which may lead to a reduction in the size of tumours or the spread of cancer to other parts of the body. Abevmy 400 mg Injection may help to reduce the risk of cancer progressing, which may improve the chances of successful long-term treatment outcomes. In some studies, Abevmy 400 mg Injection has been shown to improve survival rates in people with certain types of cancer, including colorectal, ovarian, and lung cancer.
Like all medications, Abevmy 400 mg Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Abevmy 400 mg Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Abevmy 400 mg Injection will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this Abevmy 400 mg Injection.
Abevmy 400 mg Injection blocks a vascular endothelial growth factor (VEGF), to prevent the growth of blood vessels in the tumour, it helps to stop the oxygen supply that ultimately kills the cancer cells.
It is generally not recommended to drink alcohol while taking Uses of Abevmy 400 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
patients with kidney disease should closely monitor kidney function while taking Uses of Abevmy 400 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Side effects of Abevmy 400 mg Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
It is not recommended to breastfeed while taking Side effects of Abevmy 400 mg Injection. Abevmy 400 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Side effects of Abevmy 400 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Use of Abevmy 400 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Side effects of Abevmy 400 mg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
Abevmy 400 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Side effects of Abevmy 400 mg Injection.
It is important to use caution when taking Abevmy 400 mg Injection if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
1. Avastin (bevacizumab), F. Hoffmann-la Roche Ltd , Avaliable Form
2. Bevaciptin (bevacizumab) Concentrate For Solution For Infusion , Cipla Australia Pty Ltd., [data Of Revision], Product Leaflet
3. Avastin (bevacizumab) Solution For Intravenous Infusion, Genentech, Inc. South San Francisco, Product Leaflet
4. Krabeva, Bevacizumab Injection (rDNA Origin) Concentrate For Solution For Intravenous Infusion, Biocon Biologics India Limited. India, Product Leaflet
5. Avastin 25 Mg/ml Concentrate For Solution For Infusion, Roche Pharma Ag, Germany, Available From